EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Clinical performance of self‐assembling peptide P 11 ‐4 in the treatment of initial proximal carious lesions: A practice‐based case series

Markus Schlee, Till Schad, Jan H Koch, Philippe C Cattin, Florian Rathe

Journal of Investigative and Clinical Dentistry · 2018-02 · 9 (1)

DOI: 10.1111/jicd.12286 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Investigative and Clinical Dentistry, online erschienen am 03.09.2017. Verfasst von Markus Schlee und 4 weiteren Autor:innen. Beteiligte Einrichtung: 32 Schöne Zähne, Forchheim, Germany. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Credentis AG.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

The aim of the present study was to investigate the clinical performance of self‐assembling peptide P 11 ‐4 on non‐cavitated initial proximal carious lesions 12 months after treatment.

Methods

Twenty‐six patients, aged between 18 and 65 years, with 35 carious lesions were included in this practice‐based, uncontrolled, prospective case series. The opacity and size of the proximal lesions were evaluated visually at baseline and at day 360 using standardized single‐tooth or bite‐wing and digital‐subtraction radiography. Pairwise evaluation of images was carried out in a randomized and blinded manner with respect to the time point.

Results

Twelve months after treatment of the proximal carious lesions, the visual evaluation showed a predominant shift toward regression of the initial lesions. Radiographic assessment yielded regression of the caries in 17 of 28 cases; four of 28 were regarded as unchanged, and seven of 28 lesions showed progression of the carious lesion. Combined assessment of clinical radiographs and digital subtraction radiographs confirmed the radiographic assessment, with 20 of 28 lesions showing total or partial regression, four unchanged, and four progressing.

Conclusion

Radiographic and digital subtraction analyses suggest that initial proximal carious lesions can regress after treatment with P 11 ‐4, but additional factors might influence the overall treatment outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdolescentAdultAgedBiomimetic MaterialsDental CariesFemaleHumansMaleMaterials TestingMiddle AgedOligopeptidesProspective StudiesRadiography, Dental, DigitalSurface PropertiesTooth RemineralizationYoung Adult

Stichwörter der Autor:innen

biomimeticproximal cariesregenerationremineralizationself-assembling peptide P11-4

Substanzen

OligopeptidesP11-4 peptide

Autor:innen und Institutionen

  • 32 Schöne Zähne, Forchheim, Germany.
  • Department of Maxillofacial Surgery, Goethe University, Frankfurt, Germany.
  • Dental Text and Consultancy Services, Freising, Germany.
  • Medical Image Analysis Center, University of Basel, Basle, Switzerland.
  • Department of Prosthodontics and Biomaterials, Danube Private University, Krems, Austria.

Förderung

  • Credentis AG

Zitieren

APA

Schlee, M., Schad, T., Koch, J. H., Cattin, P. C., & Rathe, F. (2018). Clinical performance of self‐assembling peptide P 11 ‐4 in the treatment of initial proximal carious lesions: A practice‐based case series. Journal of Investigative and Clinical Dentistry, 9(1). https://doi.org/10.1111/jicd.12286

Vancouver

Schlee M, Schad T, Koch JH, Cattin PC, Rathe F. Clinical performance of self‐assembling peptide P 11 ‐4 in the treatment of initial proximal carious lesions: A practice‐based case series. Journal of Investigative and Clinical Dentistry. 2018;9(1). doi:10.1111/jicd.12286

BibTeX
@article{Schlee2018,
  author = {Schlee, Markus and Schad, Till and Koch, Jan H and Cattin, Philippe C and Rathe, Florian},
  title = {Clinical performance of self‐assembling peptide P 11 ‐4 in the treatment of initial proximal carious lesions: A practice‐based case series},
  journal = {Journal of Investigative and Clinical Dentistry},
  year = {2018},
  volume = {9},
  number = {1},
  doi = {10.1111/jicd.12286}
}
Kostenlos starten →